Purchase Order 75N92019P00035
- Not listed
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $10,856.27 firm fixed price delivery order to Illumina, Inc. for goods and services to support genomic sequencing and analysis. As the sole manufacturer of the sequencing instruments in use, Illumina will provide reagents, consumables and other supplies under the delivery order citing its proprietary technology. The place of performance is the agency's location in...
- This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
- This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $383,592.54 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. The award is not set aside and was made on a sole-source basis, with Illumina identified as the sole manufacturer of the required sequencing...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $133,224.16 firm fixed price purchase order to Illumina, Inc. for a Silver Maintenance Support Plan. The contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has provided these products and related services to various federal agencies in the past, including the NIH, CDC, USDA, and VA. The award likely...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genetic analysis and sequencing instruments and reagents. The $38,900.48 contract is to provide various Illumina sequencing systems, consumables, and support services to support genomic research and diagnostics. The order was awarded under a standing purchase quote, and there was...
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $13,401.96 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products. The order is for the repair of one of the agency's Illumina DNA sequencing machines located in Bethesda, Maryland. Illumina has a history of providing sequencing instruments, reagents, and support services to various federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs, to support genomic research and diagnostic needs. The award does not appear to have any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($405) | 3/29/24 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 4/29/22 | |
| Not listed | Not listed | $13.8k | 12/13/18 |